BioCentury
ARTICLE | Distillery Therapeutics

Cancer

October 27, 2016 7:00 AM UTC

Patient sample, cell culture and mouse studies suggest inhibiting KDM6B could help treat hepatocellular carcinoma (HCC). In patients, high tumor KDM6B expression correlated with poor survival. In huma...